These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9399732)

  • 1. Symptomatic conduction system disease in cardiac amyloidosis.
    Mathew V; Olson LJ; Gertz MA; Hayes DL
    Am J Cardiol; 1997 Dec; 80(11):1491-2. PubMed ID: 9399732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraatrial conduction delay associated with an epicardial implantable cardioverter-defibrillator.
    Kocheril AG; Batsford WP
    J Electrocardiol; 1993 Oct; 26(4):341-5. PubMed ID: 8228723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment.
    Cheung CC; Roston TM; Andrade JG; Bennett MT; Davis MK
    Can J Cardiol; 2020 Mar; 36(3):416-423. PubMed ID: 32145868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.
    Varr BC; Zarafshar S; Coakley T; Liedtke M; Lafayette RA; Arai S; Schrier SL; Witteles RM
    Heart Rhythm; 2014 Jan; 11(1):158-62. PubMed ID: 24121001
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-, dual-, or triple-chamber defibrillators: the simpler the better?
    Mont L
    Heart Rhythm; 2006 Dec; 3(12):1404-5. PubMed ID: 17161780
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
    Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.
    Sharma E; Chu AF
    J Interv Card Electrophysiol; 2018 Jan; 51(1):77-86. PubMed ID: 29260369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis.
    John RM; Stern DL
    Can J Cardiol; 2020 Mar; 36(3):408-415. PubMed ID: 32037105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death.
    Lin G; Dispenzieri A; Brady PA
    Eur Heart J; 2010 Jun; 31(12):1538. PubMed ID: 20061577
    [No Abstract]   [Full Text] [Related]  

  • 11. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
    Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review.
    Alreshq R; Tugal D; Siddiqi O; Ruberg F
    Pacing Clin Electrophysiol; 2021 Dec; 44(12):2092-2099. PubMed ID: 34632598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannon A-waves due to pacemaker syndrome.
    Liang JJ; Hirshfeld JW
    Acute Card Care; 2016 Jun; 18(2):40-41. PubMed ID: 28318322
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac pacing: the state of the art.
    Trohman RG; Kim MH; Pinski SL
    Lancet; 2004 Nov 6-12; 364(9446):1701-19. PubMed ID: 15530632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating biventricular pacing morphologies: what is the cause?
    Mofrad PS; Tsiperfal A; Hsia H; Al-Ahmad A
    Heart Rhythm; 2006 Dec; 3(12):1503-4. PubMed ID: 17161798
    [No Abstract]   [Full Text] [Related]  

  • 16. Permanent pacing via implantable defibrillators.
    Pinski SL; Trohman RG
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 1):1667-82. PubMed ID: 11138305
    [No Abstract]   [Full Text] [Related]  

  • 17. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.
    Smit MD; Van Dessel PF; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Erven L; Van Veldhuisen DJ; Van Gelder IC
    Heart Rhythm; 2006 Dec; 3(12):1397-403. PubMed ID: 17161779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduction disorders after tricuspid annuloplasty with mitral valve surgery: Implications for earlier tricuspid intervention.
    Jouan J; Mele A; Florens E; Chatellier G; Carpentier A; Achouh P; Fabiani JN
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):99-103. PubMed ID: 26699770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure.
    Pattanshetty DJ; Bhat PK; Chamberlain WA; Lyons MR
    Tex Heart Inst J; 2013; 40(5):615-8. PubMed ID: 24391340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidosis and device therapy: an open debate.
    LA Franca E; Corrado E; Inga G; Ciaramitaro G; Novo S; Coppola G
    Int Angiol; 2017 Oct; 36(5):497-498. PubMed ID: 28541019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.